Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘NASDAQ:VNDA’

Paul Marshall Marshall Wace

Vanda Pharmaceuticals Inc. (VNDA): Hedge Funds In Wait-and-See Mode

As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade. Most investors who decided......(read more)
William Leland Edwards of Palo Alto Investors

Hedge Funds Have Never Been Less Bullish On Vanda Pharmaceuticals Inc. (VNDA)

Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals. They......(read more)
John Overdeck of Two Sigma

Is Vanda Pharmaceuticals Inc. (VNDA) A Good Stock To Buy?

A market surge in the first quarter, spurred by easing global macroeconomic concerns and Powell’s pivot ended up having a positive impact on the......(read more)
Brad Farber Atika Capital

Is Vanda Pharmaceuticals Inc. (VNDA) A Good Stock To Buy?

Insider Monkey has processed numerous 13F filings of hedge funds and famous investors to create an extensive database of hedge fund holdings. The 13F......(read more)

Vanda Pharmaceuticals Inc. (VNDA): Hedge Fund Sentiment Unchanged

It was a rough fourth quarter for many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

13G Filing: Armistice Capital and Vanda Pharmaceuticals Inc. (VNDA)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 10 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
pharmacist, medical, retail, worker, team, young, staff, lab, chemistry, business, drug, chemist, adult, teamwork, drugstore, service,

Hedge Funds Are Betting On Vanda Pharmaceuticals Inc. (VNDA)

The worries about the election and the ongoing uncertainty about the path of interest-rate increases have been keeping investors on the sidelines. Of......(read more)
Jeffrey Ray - Great Point Partners

This Biotech Hedge Fund’s Stock Picks Killed It in Q3

Hedge funds returned about 4% so far this year and underperformed the S&P 500 Index again. Hedge fund investors have been withdrawing their capital......(read more)
James Flynn Deerfield Management

Vanda Pharmaceuticals Inc. (VNDA) Stock: Deerfield Management Cashes In 2.56 Million Shares

According to a freshly-amended 13G filing with the Securities and Exchange Commission, James E. Flynn‘s Deerfield Management has sold around......(read more)
stock, trading, market, trader, traders, investor, investment, screen, bank, banking, share, broker, graph, business, chart, index, data, information, capital, team, money,

Here’s Why Traders Are Buzzing about These Five Stocks

Fading chances of a rate hike soothed the market sentiment on Wednesday. Some important stocks which are making headlines today, include Vornado Realty......(read more)
pharmacist, medical, retail, worker, team, young, staff, lab, chemistry, business, drug, chemist, adult, teamwork, drugstore, service,

Vanda Pharmaceuticals Inc. (VNDA)’s Stock Jumps Following NDA Approval

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)’s shares have advanced by more than 9% after the U.S. Food and Drug Administration approved Vanda’......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

13G Filing: Stonepine Capital Management, LLC Details Ownership of Vanda Pharmaceuticals Inc. (VNDA)

We are seeing a lot of 13G filing activity at the moment and one of the more interesting filings is this one submitted to the SEC by Stonepine Capital......(read more)
stocks, analysis, market, numbers, business, ticker, trade, money, price, investment, index, chart

Smart Money Is Seeing Upside For These Three Companies

Three companies have recently been the subject of bullish moves by hedge funds. Let us take a look at what makes these companies seem undervalued to hedgies......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

Are Hedge Funds Losing Interest In Vanda Pharmaceuticals Inc. (VNDA)?

Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips on the charts, usually don&#......(read more)

These Five Biotech Stocks Ranked Among This UK-based Fund’s Favorites

Cheyne Capital is one of the few non-U.S firms that we track in our database. Managed by its founders, Jonathan Lourie and Stuart Fiertz, Cheyne employs......(read more)
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)

Stonepine Capital Management Reveals 5.5% Stake in Vanda Pharmaceuticals Inc. (VNDA)

In a new filing with the Securities and Exchange Commission, Stonepine Capital Management disclosed a passive stake in Vanda Pharmaceuticals Inc. (NASDAQ......(read more)
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)

Vanda Pharmaceuticals Inc (VNDA): Deerfield Management Increases Exposure Following Positive Announcement

James Flynn’s Deerfield Management disclosed an increase in its stake in Vanda Pharmaceuticals Inc (NASDAQ:VNDA) on Friday. After adding more than 1......(read more)
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)

Tang Capital Management Discloses Moves into La Jolla Pharmaceutical Company (LJPCD), Vanda Pharmaceuticals Inc. (VNDA), Mirati Therapeutics Inc. (MRTX) & Others

Tang Capital Management, led by Kevin C. Tang, revealed in a filing several moves that have impacted its equity portfolio. One of the companies involved......(read more)
Cubist Pharmaceuticals Inc (NASDAQ:CBST)

Cubist Pharmaceuticals Inc (CBST), Trius Therapeutics, Inc. (TSRX): This Week in Biotech

With the SPDR S&P Biotech Index up 43% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the......(read more)
Sanofi SA (ADR) (NYSE:SNY)

Sanofi SA (ADR) (SNY), Vanda Pharmaceuticals Inc. (VNDA), Merck & Co., Inc. (MRK) – Sleep War Z: A Written History of the Insomniac War

It’s estimated that 30% to 40% of adults in the world experience some degree of insomnia every year. Most of these cases aren’t chronic and do not......(read more)
Micron Technology, Inc. (NASDAQ:MU)

Micron Technology, Inc. (MU) Calls Change Hands At A Clip Ahead of Earnings After The Close

Micron Technology, Inc. (NASDAQ:MU) – Options traders appear to be snapping up out of the money call options on Micron Technology, Inc. (NASDAQ:MU) ......(read more)

Discovery Laboratories, Inc. (DSCO): Are Hedge Funds Right About This Stock?

Is Discovery Laboratories, Inc. (NASDAQ:DSCO) a healthy stock for your portfolio? Investors who are in the know are getting less optimistic. The number......(read more)
Raptor Pharmaceutical Corp. (NASDAQ:RPTP)

Assessing Raptor Pharmaceutical Corp. (RPTP)’s Agreement With HealthCare Royalty Partners

Raptor Pharmaceutical Corp. (NASDAQ:RPTP) signed an agreement with HealthCare Royalty Partners. On the face, this deal looks good for shareholders injecting......(read more)
Bristol Myers Squibb Co. (NYSE:BMY)

Bristol Myers Squibb Co (BMY), Momenta Pharmaceuticals, Inc. (MNTA): White Collar Criminals Love Biotech Stocks

It’s understandably very tempting for people with inside information to trade biotech stocks. With the potential for overnight doubles and triples......(read more)
Steven Cohen

Hedge Funds Have Bought Lamar Advertising Co (LAMR), ITT Educational Services, Inc. (ESI) & More

The most comprehensive picture of hedge fund activity comes in the form of quarterly 13F filings. While the information in these filings is a bit old......(read more)
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)

Baker Bros. Advisors Boosts Stake in Vanda Pharmaceuticals Inc. (VNDA)

In the hedge fund world, Julian Baker and Felix Baker’s Baker Bros. Advisors reported a purchase of 2,028,789 shares in Vanda Pharmaceuticals Inc. (......(read more)
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)

This Metric Says You Are Smart to Buy Vanda Pharmaceuticals Inc. (VNDA)

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) has experienced an increase in enthusiasm from smart money in recent months. In the 21st century investor’s......(read more)

Avoid This Biotech Stock: Chelsea Therapeutics International Ltd. (CHTP)

Editor’s note: This article is a stock pitch made by a member on CAPS, The Motley Fool’s free investing community. The pitch is published......(read more)